EUVIMEDEUVIMED entdecken
Crossref

Effect of a TNF-Alpha Inhibitor on Anxiety and Depression-Like Behaviors in a Mouse Chemobrain Model

Mehmet ÖZ, Nurhan AKARAS

New Trends in Medicine Sciences · 2023

DOI: 10.56766/ntms.1239435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Trends in Medicine Sciences, 2023. Verfasst von Mehmet ÖZ und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although chemotherapy increases the survival rate of cancer patients, it causes significant side effects such as deterioration in cognitive functions that generate a decline in their living standards. In our study, the effect of adalimumab on anxiety- and depression-like behaviors in mice with cognitive impairment with methotrexate was investigated. In our study, methotrexate (40 mg kg-1) was administered intraperitoneally as a single dose to create a chemobrain model in mice. Adalimumab (10 mg kg-1), a TNF-alpha inhibitor, was administered twice, 1 hour and 5 days before methotrexate administration. Anxiety-like behaviors were measured with elevated plus maze test and open field test, depression-like behaviors were measured with tail suspension test, and hippocampal tissue was examined histopathologically. Methotrexate decreased the time spent in the central zone in the open-field arena, the time spent in the open arms in the elevated plus maze test, and increased the duration of immobility in the tail suspension test in rats. Methotrexate caused a decrease in the number of neuronal cells in the CA3 region of the hippocampus, as well as neurodegenerative and atrophic changes. Adalimumab ameliorated methotrexate-related anxiety- and depression-like behaviors, and caused improvement in histopathological changes. In this study, it was shown that methotrexate-related anxiety and depression-like behavioral disorders were prevented by adalimumab treatment, but further studies are recommended to investigate the mechanisms mediating the therapeutic effect of adalimumab.

Zitieren

APA

ÖZ, M., & AKARAS, N. (2023). Effect of a TNF-Alpha Inhibitor on Anxiety and Depression-Like Behaviors in a Mouse Chemobrain Model. New Trends in Medicine Sciences. https://doi.org/10.56766/ntms.1239435

Vancouver

ÖZ M, AKARAS N. Effect of a TNF-Alpha Inhibitor on Anxiety and Depression-Like Behaviors in a Mouse Chemobrain Model. New Trends in Medicine Sciences. 2023. doi:10.56766/ntms.1239435

BibTeX
@article{Z2023,
  author = {ÖZ, Mehmet and AKARAS, Nurhan},
  title = {Effect of a TNF-Alpha Inhibitor on Anxiety and Depression-Like Behaviors in a Mouse Chemobrain Model},
  journal = {New Trends in Medicine Sciences},
  year = {2023},
  doi = {10.56766/ntms.1239435}
}
Kostenlos starten →